These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 30601137)

  • 1. Functional significance of the platelet immune receptors GPVI and CLEC-2.
    Rayes J; Watson SP; Nieswandt B
    J Clin Invest; 2019 Jan; 129(1):12-23. PubMed ID: 30601137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
    Lee RH; Bergmeier W
    J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
    Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
    J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2.
    Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ
    J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.
    Rayes J; Lax S; Wichaiyo S; Watson SK; Di Y; Lombard S; Grygielska B; Smith SW; Skordilis K; Watson SP
    Nat Commun; 2017 Dec; 8(1):2239. PubMed ID: 29269852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases.
    Harbi MH; Smith CW; Nicolson PLR; Watson SP; Thomas MR
    Platelets; 2021 Jan; 32(1):29-41. PubMed ID: 33307909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice.
    Bender M; May F; Lorenz V; Thielmann I; Hagedorn I; Finney BA; Vögtle T; Remer K; Braun A; Bösl M; Watson SP; Nieswandt B
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):926-34. PubMed ID: 23448972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPVI and CLEC-2 in hemostasis and vascular integrity.
    Watson SP; Herbert JM; Pollitt AY
    J Thromb Haemost; 2010 Jul; 8(7):1456-67. PubMed ID: 20345705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice.
    Wichaiyo S; Lax S; Montague SJ; Li Z; Grygielska B; Pike JA; Haining EJ; Brill A; Watson SP; Rayes J
    Haematologica; 2019 Aug; 104(8):1648-1660. PubMed ID: 30733265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
    Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
    Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands.
    Alshehri OM; Montague S; Watson S; Carter P; Sarker N; Manne BK; Miller JL; Herr AB; Pollitt AY; O'Callaghan CA; Kunapuli S; Arman M; Hughes CE; Watson SP
    Biochem J; 2015 Jun; 468(3):459-73. PubMed ID: 25849538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
    Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI.
    Ozaki Y; Suzuki-Inoue K; Inoue O
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():191-4. PubMed ID: 19630798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane lipid rafts protein composition varies following GPVI and CLEC-2 receptors activation.
    Izquierdo I; Barrachina MN; Hermida-Nogueira L; Casas V; Eble JA; Carrascal M; Abián J; García Á
    J Proteomics; 2019 Mar; 195():88-97. PubMed ID: 30677554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel platelet activation receptor CLEC-2: from discovery to prospects.
    Suzuki-Inoue K; Inoue O; Ozaki Y
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():44-55. PubMed ID: 21781241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ.
    Oishi S; Tsukiji N; Otake S; Oishi N; Sasaki T; Shirai T; Yoshikawa Y; Takano K; Shinmori H; Inukai T; Kondo T; Suzuki-Inoue K
    Blood Adv; 2021 Apr; 5(7):2017-2026. PubMed ID: 33843987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
    Meng D; Luo M; Liu B
    Front Immunol; 2021; 12():688643. PubMed ID: 34177942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the GPVI inhibitors losartan and honokiol.
    Onselaer MB; Nagy M; Pallini C; Pike JA; Perrella G; Quintanilla LG; Eble JA; Poulter NS; Heemskerk JWM; Watson SP
    Platelets; 2020; 31(2):187-197. PubMed ID: 30849265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.